Navigation Links
Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
Date:4/2/2009

f the date of this press release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, while Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.


'/>"/>
SOURCE Cynosure, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... At today,s regular meeting of the board of directors ... the board declared a regular quarterly dividend of 31 ... of record at the close of business on February ... ,, The Lubrizol Corporation (NYSE: LZ ) ... supplies technologies that improve the quality and performance of ...
(Date:12/15/2009)... Ind., Dec. 15 Today, Hill-Rom Holdings, ... investors regarding progress on significant strategic and financial ... City. The Conference is hosted by Peter ... will include presentations on the following topics: ,, ... unit, research and development and financial updates ...
(Date:12/15/2009)... HAVEN, Conn., Dec. 15 Rib-X Pharmaceuticals, ... and commercialization of novel drugs for the treatment ... entered into a collaborative research agreement with Massachusetts ... science plan for the collaboration, Dr. David Hooper ... in an established animal model to determine resistance ...
Breaking Medicine Technology:Lubrizol Declares Dividend 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 1Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 2Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 3Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 4Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 62412 1Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 62412 2Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 62407 1Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 62407 2
... Ambulatory BP MeasuresPARSIPPANY, N.J., May 8 Daiichi Sankyo, ... Society of Hypertension, Inc. (ASH) Twenty-Fourth Annual Scientific Meeting ... AZ OR(R) T rial E valuating ... ) demonstrated that a stepwise amlodipine and olmesartan medoxomil-based ...
... Inc. (Nasdaq: BNVI ) today announced first quarter ... 31, 2009. Company Highlights , ... on a preclinical anti-cancer drug candidate, BN108, at the American ... has been identified as an active compound of BN108 that ...
Other Medicine Technology:New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 2New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 3New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 4New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 5New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 6New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 7New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 8New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 9Bionovo Announces First Quarter 2009 Highlights and Financial Results 2Bionovo Announces First Quarter 2009 Highlights and Financial Results 3Bionovo Announces First Quarter 2009 Highlights and Financial Results 4Bionovo Announces First Quarter 2009 Highlights and Financial Results 5Bionovo Announces First Quarter 2009 Highlights and Financial Results 6
(Date:12/15/2009)... Dec. 15 Hospira, Inc. (NYSE: ... in generic injectable pharmaceuticals, and Orchid Chemicals ... a leading Indian pharmaceuticals company and among ... today announced an agreement for Hospira to ... business for approximately $400 million. ,, ...
(Date:12/15/2009)... treated with hormones, but when the tumours start growing ... a thesis from the Sahlgrenska Academy, at the University ... new treatments for hormone-resistant prostate cancer. , Late in ... has spread, most patients are given hormone therapy. This ... the tumour shrinks. , "The problem is that the ...
(Date:12/15/2009)... international team of Canadian and Spanish scientists have found ... develop severe pneumonia when infected by the pandemic H1N1 ... regulating molecules for 20 hospitalized patients, 15 outpatients and ... first pandemic wave in July and August 2009. Researchers ... and the University Health Network found high levels of ...
(Date:12/15/2009)... users to control the volume without compromising sound-quality or comfort. ... ... 15, 2009 -- EarPeace ( www.earpeace.com ) is redefining hearing ... in three different skin-tone colors. "As a big fan of ... I was looking for a way to continue my active ...
(Date:12/15/2009)... Volume Injections Dangerous , ... New ... hype surrounding buttock augmentation and other large-volume body enhancing injections ... an alarming and potentially deadly trend, cautions the Physicians ... polymethylmethacrylate (PMMA), silicone, and polyacrylimide used in augmenting buttocks, hips, ...
Breaking Medicine News(10 mins):Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 2Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 3Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 4Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 5Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 6Health News:More blood vessels in hormone-resistant prostate tumors 2Health News:First immunological clue to why some H1N1 patients get very ill or die 2Health News:EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 3Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 4
... zero in on a DNA cluster that may encourage ... Mexican-Americans carrying what,s known as a haplotype of a ... a new study finds. , Haplotypes are clusters of ... the University of Kansas Medical Center (UKMC)collected blood samples ...
... 13 Allarae Healthcare,Inc. (Pink Sheets: ALHI) announced today ... to sell their entire product line on a,non-exclusive basis, ... health testing kits, several already FDA approved, and personal,tracking ... for market but have,not yet been commercialized., The ...
... WELLINGTON, Fla., Dec. 13 The Quantum Group,Inc. ... that it,has completed its registered public offering, raising ... that it has initiated trading,on the American Stock ... under the symbol "QGP.U." In addition, Quantum common ...
... Network Foundation for the Hospital,s ... State-of-the-Art Cardiothoracic Center, SANTA CLARA, ... completion of a new network,infrastructure to support a trust-wide ... Thurrock University Hospitals, part,of the NHS Foundation Trust in ...
... create new dental plan services for members, ... (GDS) /,Denex, provider of comprehensive dental plans and ... a division of the,nation,s leading integrated health plan ... processing, network access and,call center support to Kaiser ...
... Getting in shape shouldn,t feel like,getting your teeth ... veteran of the fitness industry. For anyone who,s vowed ... a novel fitness,program to help them get going. Recently ... people to "ease into," exercise,going at their own pace, ...
Other Medicine News:Health News:Genetics May Boost Mexican-Americans' Risk for Alcoholism 2Health News:Allarae Healthcare Inc. Announces Signing of Distribution Agreement With Intellect Inc. 2Health News:The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP' 2Health News:The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP' 3Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 3Health News:Fitness Guru Offers Novel Exercise Program and Tips to Stick with Exercise in the New Year 2
... of 96 tips, Sterilized Diamond- Tips are ... Diamond Tips are irradiated by gamma-rays for ... a certificate of sterilization, specifying the date ... free of detectable Rnase, Dnase, DNA, RNA, ...
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
For the quantitative determination of luteinizing hormone (LH) concentration in human serum....
Medicine Products: